Haleon plc (HLN)

NYSE · Healthcare · Drug Manufacturers - Specialty & Generic
$9.07+0.22%As of 2026-11-22 · USD
Last session low $9.07Last session high $9.16
52-week low $8.3852-week high $11.28
Market cap
$39.76B
Sector
Healthcare
P/E (TTM)
18.5x
Dividend yield
2.18%

Market data and research context for informational purposes. Not investment advice.

Technical indicators

Indicators from the 2026-11-20 daily bar; Bollinger %B and the average rows compare the latest price with those values. Prices in USD.

IndicatorValueReading
RSI (14)46.0In the neutral range (30 to 70)
MACD (12, 26, 9)-0.11Level with its signal line (-0.11)
Bollinger %B (20, 2)44%Inside the bands (8.33 to 10.02)
SMA 209.18Price is 1.2% below
SMA 509.32Price is 2.7% below
SMA 2009.67Price is 6.2% below
ATR (20)2.32% of priceAverage true range per day
52-week position24%In the lower part of the 8.38 to 11.28 range

About Haleon plc

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.

Insider filings, 90 days1 purchase (about $20K) and no sales.
Latest fiscal yearEnded 2025-12-31: revenue of 11.03B GBP and an operating margin of 21.9%.

Also listed as HLN.L (LSE)

More in Drug Manufacturers - Specialty & Generic